The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Nicotine receptor partial agonists for smoking cessation
Open accessAbstract
Nicotine receptor partial agonists for smoking cessation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of effective drugs to treat nicotine-dependence (e.g., nicotine patches, nicotine gum, and varenicline)356, 357) combined with counseling for psychological dependence increase the success rate of smoking cessation.”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [356]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,564
Self-citationAntidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
Pharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243
Self-citationAnthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1093/ntr/5.1.13 · Cited by 1,058
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Research works printed but not linked: 38
- Aubin, 2008, Authors' reply [to JE Rose], Thorax, 63, 752
- Aubin, 2008, Authors' reply [to T Hillman], Thorax, 63, 752
- Brinn, 2013, Cost effectiveness of an inpatient smoking cessation intervention for patients with tobacco related illnesses (Stop Trial): a multi-centre RCT [Abstract], Respirology (Carlton, Vic.), 18, 16 [O027]
- Carson, 2015, Superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 24-month randomized controlled trial for inpatients, Respirology, 20, 115
- Carson, 2010, Varenicline tartrate and counselling versus counselling alone in a randomised controlled trial for inpatient smoking cessation: 3 month interim results [Abstract], Respirology, 15, A30
- Hnin, 2014, Triggers resulting in relapse: cohort analysis from the smoking termination opportunity for inpatients (STOP) trial [Abstract], Respirology (Carlton, Vic.), 19, 40 [TO 076]
- Anthenelli R Benowitz N West R St Aubin L McRae T Lawrence D Reports of suicidal ideation and behavior in the EAGLES trial Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 8
- Benowitz N Evins AE West R St Aubin L McRae T Lawrence D EAGLES trial: study design and neuropsychiatric safety results Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
- Prochaska J Neuropsychiatric risk concerns in the context of smoking, quitting, and cessation pharmacotherapy use Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
- Prochaska J Benowitz N West R Anthenelli R Evaluating adverse events in a global smoking cessation study (EAGLES): a randomized controlled tiral comparing the safety and efficacy of the first-line smoking cessation aids in smokers with and without pychiatric disorders Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
- West R Benowitz N Evins AE St Aubin L McRae T Lawrence D Relative efficacy of varenicline, bupropion SR, and nicotine transdermal patch in aiding smoking cessation in the EAGLES trial Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 8
- Bastian H Comment on Ebbert 2015 'Reduce to Quit' trial www.ncbi.nlm.nih.gov/pubmed/?term=25688780
- Evins, 2013, Extended duration pharmacotherapy with varenicline prevents relapse to smoking in adult smokers with schizophrenia, Neuropsychopharmacology, 38, S63
- Meszaros, 2012, Varenicline treatment of alcohol and nicotine dependence in schizophrenia: Problems encountered in a pilot trial, American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 21, 393
- Nakamura, 2007, Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers, Clinical Therapeutics, 29, 1040, 10.1016/j.clinthera.2007.06.012 · DOI
- Rigotti, 2010, A randomized trial of varenicline for smoking cessation in patients with cardiovascular disease: analysis of efficacy by baseline characteristics, Circulation, Conference, 2
- Benndorf, 1970, Smoking cessation treatment with cytisin (Tabex®): half-yearly outcomes for former smokers abstinent at four weeks from beginning of treatment, Das Deutsche Gesundheitwesen, 24, 774
- Benndorf, 1969, Further reports on a double blind trial of the Bulgarian cytisine compound Tabex® on 1214 smokers wishing to quit and practical experience in conducting clinics for such smokers, Das Deutsche Gesundheitswesen, 24, 1135
- Benndorf, 1968, Results of smoking cessation treatment with cytisin (Tabex®), Das Deutsche Gesundheitwesen, 23, 2092
- Scharfenberg, 1971, Cytisine (Tabex®) as a treatment for smoking cessation, Das Deutsche Gesundheitwesen, 26, 463
- O'Brien, 2007, Varenicline as maintenance therapy, Current Psychiatry Reports, 9, 348
- Fagerström, 2010, Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries, Current medical Research & Opinion, 26, 2165, 10.1185/03007995.2010.505130 · DOI
- Fagerström, 2010, Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries, Current medical Research & Opinion, 26, 2165, 10.1185/03007995.2010.505130 · DOI
- Westergaard, 2014, The effect of varenicline on smoking cessation in a group of young asthma patients, American Journal of Respiratory and Critical Care Medicine, 189, A1091
- Reeves K Watsky E Williams K Azoulay S Billing B Gong J The safety of varenicline taken for 52 weeks for smoking cessation [RPOS3-54] Society for Research on Nicotine and Tobacco 12th Annual Conference Orlando Fla, USA 2006
- Falk, 2014, A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence, Alcoholism, Clinical and Experimental Research, 38, 139A
- Granatowicz, 1976, Smoking cessation through the use of cytisine and other therapy, World Smoking Health, 1, 8
- Hartwell, 2014, Pharmacogenetics of naltrexone and varenicline in heavy drinking smokers, Alcoholism, Clinical and Experimental Research, 38, 223A
- Bacvarov, 1967, Smoking cessation through medication: remarks on G. Scharfenberg, E Winkelvoss and S. Benndorf, Munch Med Wschr. 109 (1967) 1687-1689, Munchener Medizinische Wochenschrift, 109, 2663
- Kempe, 1967, Observation about the Bulgarian medicine for smoking withdrawal Tabex, produced by Pharmachim-Sofia, Savr Med, 18, 355
- Paun, 1968, [Smoking cessation with cytisine 'Tabex' tablets] [German], Sonderduck aus das deutsche Gesundheitwesen, 23, 2088
- Paun, 1970, Tabex: registering and treatment of smokers with chronic bronchitis in the consultation against tobacco smoking - Berlin, Medico-Biologic Information, 3, 15
- Shim, 2011, Varenicline treatment for smoking cessation in people with schizophrenia: a randomized double-blind placebo-controlled trial, Schizophrenia Bulletin, 37, 320
- Stoyanov, 1972, [On the therapeutic effectiveness and tolerability of Tabex] [Bulgarian], Savremenna Medicina, 23, 30
- Wiratmoko, 2013, Efficacy of varenicline, an nicotinic acetylcholine receptor partial agonist, vs placebo for smoking cessation. A randomized controlled trial, Respirology (Carlton, Vic.), 18, 66 [OS205]
- Reid, 2010, Varenicline versus transdermal nicotine patch for smoking cessation in patients with coronary heart disease: A pilot randomized trial, Canadian Journal of Cardiology, 26, 53D
- Smith, 2013, Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia, Neuropsychopharmacology, 38, S364
- Tutka, 2006, Cytisine - renaissance of well known alkaloid. Pharmacological aspects of efficacy in the treatment of tobacco dependence [Polish], Farmakoterapia w Psychiatrii i Neurologii, 1, 33
Cited by
Sorted by citations
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis‐Holland, J. E., Bangalore, S., Bates, E., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,691
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Electronic cigarettes for smoking cessation
Hartmann‐Boyce, J., McRobbie, H. J., Bullen, C., Begh, R. A., Stead, L. F., & Hájek, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub3 · Cited by 1,217
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Nicotine replacement therapy versus control for smoking cessation
Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub5 · Cited by 697
Self-citationTobacco smoking: health impact, prevalence, correlates and interventions
West, R. (2017) · Psychology & Health · doi:10.1080/08870446.2017.1325890 · Cited by 694
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
Himmelstein, D. S., Lizee, A., Hessler, C., Brueggeman, L., Chen, S. L., Hadley, D., Green, A., Khankhanian, P., & Baranzini, S. E. (2017) · eLife · doi:10.7554/elife.26726 · Cited by 666
Psychosocial interventions for supporting women to stop smoking in pregnancy
Chamberlain, C., O'Mara-Eves, A., Porter, J., Coleman, T., Perlen, S. M., Thomas, J., & McKenzie, J. E. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub5 · Cited by 650
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab154 · Cited by 586
Weight gain in smokers after quitting cigarettes: meta-analysis
Aubin, H.-J., Farley, A., Lycett, D., Lahmek, P., & Aveyard, P. (2012) · BMJ · doi:10.1136/bmj.e4439 · Cited by 510
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2021) · JAMA · doi:10.1001/jama.2020.25019 · Cited by 512
Volkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503
Smoking and the risk of type 2 diabetes
Maddatu, J., Anderson‐Baucum, E. K., & Evans‐Molina, C. (2017) · Translational research · doi:10.1016/j.trsl.2017.02.004 · Cited by 403
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Treatment of Tobacco Smoking: A Review
Rigotti, N. A., Kruse, G. R., Livingstone-Banks, J., & Hartmann-Boyce, J. (2022) · JAMA · doi:10.1001/jama.2022.0395 · Cited by 361
2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment
Barua, R. S., Rigotti, N. A., Benowitz, N. L., Cummings, K. M., Jazayeri, M., Morris, P. B., Ratchford, E. V., Sarna, L., Stecker, E. C., & Wiggins, B. S. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.027 · Cited by 391
Electronic cigarettes for smoking cessation
Hartmann‐Boyce, J., McRobbie, H. J., Lindson, N., Bullen, C., Begh, R., Theodoulou, A., Notley, C. J., Rigotti, N. A., Turner, T., Butler, A. R., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub4 · Cited by 341
Self-citationElectronic cigarettes for smoking cessation
Hartmann-Boyce, J., Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub7 · Cited by 320
Self-citation2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rosselló, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad107 · Cited by 373
Electronic cigarettes for smoking cessation
Hartmann‐Boyce, J., McRobbie, H. J., Butler, A. R., Lindson, N., Bullen, C., Begh, R. A., Theodoulou, A., Notley, C. J., Rigotti, N. A., Turner, T., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub5 · Cited by 319
Self-citationOkamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 345
Interventions to reduce harm from continued tobacco use
Lindson, N., Hartmann‐Boyce, J., Fanshawe, T. R., Begh, R. A., Farley, A., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005231.pub3 · Cited by 273
Self-citationLindson, N., Chepkin, S. C., Ye, W., Fanshawe, T. R., Bullen, C., & Hartmann-Boyce, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013308 · Cited by 254
Self-citationMorley, R., Sharma, A. K., Horsch, A. D., & Hinchliffe, R. J. (2018) · BMJ · doi:10.1136/bmj.j5842 · Cited by 239
Interventions for Tobacco Cessation in Adults, Including Pregnant Persons
Patnode, C. D., Henderson, J. T., Coppola, E. L., Melnikow, J., Durbin, S., & Thomas, R. G. (2021) · JAMA · doi:10.1001/jama.2020.23541 · Cited by 212
Non–Small Cell Lung Cancer, Version 1.2015
Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., Cheney, R. T., Chirieac, L. R., D’Amico, T. A., Demmy, T. L., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0176 · Cited by 215
Pharmacological interventions for promoting smoking cessation during pregnancy
Claire, R., Chamberlain, C., Davey, M.-A., Cooper, S. E., Berlin, I., Leonardi-Bee, J., & Coleman, T. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub3 · Cited by 188
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation
Hartmann-Boyce, J., Hong, B., Livingstone-Banks, J., Wheat, H., & Fanshawe, T. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009670.pub4 · Cited by 186
Self-citationLindson, N., Theodoulou, A., Ordóñez-Mena, J. M., Fanshawe, T. R., Sutton, A. J., Livingstone‐Banks, J., Hajizadeh, A., Zhu, S., Aveyard, P. N., Freeman, S. C., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015226.pub2 · Cited by 189
Self-citationClinical Effects of Cigarette Smoking: Epidemiologic Impact and Review of Pharmacotherapy Options
Onor, I. O., Stirling, D., Williams, S. R., Bediako, D., Borghol, A., Harris, M. B., Darensburg, T. B., Clay, S. D., Okpechi, S. C., & Sarpong, D. F. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14101147 · Cited by 173
Electronic cigarettes for smoking cessation
Hartmann‐Boyce, J., McRobbie, H. J., Butler, A. R., Lindson, N., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub6 · Cited by 184
Self-citationNursing interventions for smoking cessation
Rice, V. H., Heath, L., Livingstone‐Banks, J., & Hartmann‐Boyce, J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001188.pub5 · Cited by 186
Bentzley, B. S., Han, S. S., Neuner, S., Humphreys, K., Kampman, K. M., & Halpern, C. H. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8049 · Cited by 161
Thomas, K. H., Dalili, M. N., López-López, J. A., Keeney, E., Phillippo, D., Munafo, M. R., Stevenson, M., Caldwell, D. M., & Welton, N. J. (2021) · Health Technology Assessment · doi:10.3310/hta25590 · Cited by 163
Self-citationCeceli, A. O., Bradberry, C. W., & Goldstein, R. Z. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01153-9 · Cited by 150
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. M., Викторович, А. М., Alexandrova, L. M., Анциферова, А. А., Dm, A., Ахмеджанов, Н. М., Balanova, Y. А., et al. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3235 · Cited by 197
Heated tobacco products for smoking cessation and reducing smoking prevalence
Tattan‐Birch, H., Hartmann‐Boyce, J., Kock, L. S., Simonavicius, E., Brose, L. S., Jackson, S. E., Shahab, L., & Brown, J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013790.pub2 · Cited by 147
Nicotinic acetylcholine receptors in neuropathic and inflammatory pain
Hone, A. J., & McIntosh, J. M. (2017) · FEBS Letters · doi:10.1002/1873-3468.12884 · Cited by 135
Smoking reduction interventions for smoking cessation
Lindson, N., Klemperer, E., Hong, B., Ordóñez-Mena, J. M., & Aveyard, P. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013183.pub2 · Cited by 133
Self-citationTobacco use and cessation for cancer survivors: An overview for clinicians
Karam‐Hage, M., Cinciripini, P. M., & Gritz, E. R. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21231 · Cited by 123
Xiao, C., Zhou, C., Jiang, J., & Cui, Y. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0299-4 · Cited by 124
Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease
Abramson, B. L., Al-Omran, M. A., Anand, S. S., Albalawi, Z., Coutinho, T. A., de Mestral, C., Dubois, L. A., Gill, H. L., Greco, E., Guzman, R., et al. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.02.029 · Cited by 133
Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial
Courtney, R. J., McRobbie, H., Tutka, P., Weaver, N. A., Petrie, D., Mendelsohn, C. P., Shakeshaft, A., Talukder, S., Macdonald, C., Thomas, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.7621 · Cited by 118
Electronic cigarettes for smoking cessation.
(2012) · PubMed · Cited by 115
Hindocha, C., Freeman, T. P., Grabski, M., Stroud, J., Crudgington, H., Davies, A. C., Das, R., Lawn, W., Morgan, C. J. A., & Curran, H. V. (2018) · Addiction · doi:10.1111/add.14243 · Cited by 107
Nicotine receptor partial agonists for smoking cessation
Livingstone‐Banks, J., Fanshawe, T. R., Thomas, K. H., Theodoulou, A., Hajizadeh, A., Hartman, L., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub8 · Cited by 108
Self-citationWhat phytotherapy needs: Evidence‐based guidelines for better clinical practice
Colalto, C. (2017) · Phytotherapy Research · doi:10.1002/ptr.5977 · Cited by 98
Prevention and Treatment of Tobacco Use
Kalkhoran, S. M., Benowitz, N. L., & Rigotti, N. A. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.036 · Cited by 108
Interventions for preventing weight gain after smoking cessation
Hartmann‐Boyce, J., Theodoulou, A., Farley, A., Hájek, P., Lycett, D., Jones, L. L., Kudlek, L., Heath, L., Hajizadeh, A., Schenkels, M., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006219.pub4 · Cited by 100
Relapse prevention interventions for smoking cessation
Livingstone-Banks, J., Norris, E., Hartmann-Boyce, J., West, R., Jarvis, M., & Hajek, P. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003999.pub5 · Cited by 94
O’Malley, S. S., Zweben, A., Fucito, L. M., Wu, R., Piepmeier, M. E., Ockert, D. M., Bold, K. W., Petrakis, I. L., Muvvala, S. B., Jatlow, P. I., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3544 · Cited by 94
Discovery and development of varenicline for smoking cessation
Jordan, C. J., & Xi, Z. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1458090 · Cited by 103
The endocannabinoid system as a target for addiction treatment: Trials and tribulations
Sloan, M. E., Gowin, J. L., Ramchandani, V. A., Hurd, Y. L., & Foll, B. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.031 · Cited by 94
Smoking cessation in pregnancy: a continuing challenge in the United States
Scherman, A. J., Tolosa, J. E., & McEvoy, C. T. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098618775366 · Cited by 85
Lengsfeld, S., Burkard, T., Meienberg, A., Jeanloz, N., Vukajlovic, T., Bologna, K., Steinmetz, M., Bathelt, C., Sailer, C. O., Vogt, D., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101865 · Cited by 90
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J. M., Capodanno, D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.016 · Cited by 89
Relapse prevention interventions for smoking cessation
Livingstone-Banks, J., Norris, E., Hartmann-Boyce, J., West, R., Jarvis, M., Chubb, E., & Hajek, P. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003999.pub6 · Cited by 77
Walker, N. K., Smith, B. D., Barnes, J., Verbiest, M. E. A., Parag, V., Pokhrel, S., Wharakura, M., Lees, T., Gutierrez, H. C., Jones, B., et al. (2021) · Addiction · doi:10.1111/add.15489 · Cited by 82
Cytisine and cytisine derivatives. More than smoking cessation aids
Gotti, C., & Clementi, F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105700 · Cited by 86
Mersha, A. G., Gould, G. S., Bovill, M., & Eftekhari, P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238895 · Cited by 73
Kuschner, W. G., Reddy, Mehrotra, N., Paintal, Reddy, S., & Mehrotra, N. (2011) · International Journal of General Medicine · doi:10.2147/ijgm.s16908 · Cited by 73
Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking
Gómez‐Coronado, N., Walker, A. J., Berk, M., & Dodd, S. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2073 · Cited by 74
Валерьевич, А. О., HARUTYUNYAN, G., Duplyakov, D. V., Константинова, Е. В., Konstantinova, N. N., Shakhnovich, R. M., Yavelov, I. S., Yakovlev, A. N., Sa, A., Alekyan, B. G., et al. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6306 · Cited by 86
Cadham, C. J., Cao, P., Jayasekera, J. C., Taylor, K. L., Levy, D. T., Jeon, J., Elkin, E. B., Foley, K. L., Joseph, A. M., Kong, C. Y., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab002 · Cited by 70
Nicotine receptor partial agonists for smoking cessation
Livingstone‐Banks, J., Fanshawe, T. R., Thomas, K. H., Theodoulou, A., Hajizadeh, A., Hartman, L., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub9 · Cited by 77
Self-citationTibuakuu, M., Okunrintemi, V., Jirru, E., Echouffo-Tcheugui, J. B., Orimoloye, O. A., Mehta, P. K., DeFilippis, A. P., Blaha, M. J., & Michos, E. D. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.4585 · Cited by 67
Effects of varenicline on subjective craving and relative reinforcing value of cigarettes
Green, R., & Ray, L. A. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.03.037 · Cited by 65
Jackson, S. E., McGowan, J., Ubhi, H. K., Proudfoot, H., Shahab, L., Brown, J., & West, R. (2019) · Addiction · doi:10.1111/add.14549 · Cited by 65
Carrasco-Hernandez, L., Jódar-Sánchez, F., Núñez-Benjumea, F., Moreno Conde, J., Mesa González, M., Civit-Balcells, A., Hors-Fraile, S., Parra-Calderón, C. L., Bamidis, P. D., & Ortega-Ruiz, F. (2020) · JMIR mHealth and uHealth · doi:10.2196/17530 · Cited by 65
Kastaun, S., Brown, J., Brose, L. S., Ratschen, E., Raupach, T., Nowak, D., Cholmakow-Bodechtel, C., Shahab, L., West, R., & Kotz, D. (2017) · BMC Public Health · doi:10.1186/s12889-017-4328-2 · Cited by 64
Smoking cessation and response to periodontal treatment
Alexandridi, F., Tsantila, S., & Pepelassi, E. (2017) · Australian Dental Journal · doi:10.1111/adj.12568 · Cited by 67
Das, S., & Prochaska, J. J. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1361823 · Cited by 60
Havard, A., Chandran, J. J., & Oei, J. L. (2022) · Addiction · doi:10.1111/add.15792 · Cited by 58
Reitz, K. M., Althouse, A. D., Meyer, J., Arya, S., Goodney, P. P., Shireman, P. K., Hall, D. E., & Tzeng, E. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.3979 · Cited by 56
Real-time video counselling for smoking cessation
Tzelepis, F., Paul, C. L., Williams, C. M., Gilligan, C., Regan, T. W., Daly, J., Hodder, R. K., Byrnes, E., Byaruhanga, J., McFadyen, T., et al. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012659.pub2 · Cited by 59
Thomas, K. H., Dalili, M. N., López-López, J. A., Keeney, E., Phillippo, D., Munafo, M. R., Stevenson, M., Caldwell, D. M., & Welton, N. J. (2021) · Addiction · doi:10.1111/add.15675 · Cited by 48
Self-citationSmoking Cessation and Benefits to Cardiovascular Health: A Review of Literature
Okorare, O., Evbayekha, E. O., Adabale, O. K., Daniel, E., Ubokudum, D., Olusiji, S., & Antia, A. U. (2023) · Cureus · doi:10.7759/cureus.35966 · Cited by 49
Interventions to increase adherence to medications for tobacco dependence
Hollands, G. J., Naughton, F., Farley, A., Lindson, N., & Aveyard, P. N. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009164.pub3 · Cited by 50
Lifestyle management to prevent atherosclerotic cardiovascular disease: evidence and challenges
Trier, T. J. V., Mohammadnia, N., Snaterse, M., Peters, R. J. G., Jorstad, H. T., & Bax, W. A. (2021) · Netherlands Heart Journal · doi:10.1007/s12471-021-01642-y · Cited by 56
Ashare, R. L., Thompson, M., Serrano, K., Leone, F. T., Metzger, D. S., Frank, I., Gross, R., Hole, A. V., Mounzer, K., Collman, R. G., et al. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.03.011 · Cited by 47
New steps for treating alcohol use disorder
Campbell, E. J., Lawrence, A. J., & Perry, C. J. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4887-7 · Cited by 49
An Online Weight Loss Intervention for People With Obesity and Poorly Controlled Asthma
Johnson, O., Gerald, L. B., Harvey, J. R., Roy, G., Hazucha, H., Large, C., Burke, A. E., McCormack, M. C., Wise, R. A., Holbrook, J. T., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.02.040 · Cited by 46
Selby, P. L., & Zawertailo, L. A. (2022) · New England Journal of Medicine · doi:10.1056/nejmcp2032393 · Cited by 47
The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?
Pomrenze, M. B., Fetterly, T. L., Winder, D. G., & Messing, R. O. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13507 · Cited by 46
Pastorino, U., Ladisa, V., Trussardo, S., Sabia, F., Rolli, L., Valsecchi, C., Ledda, R. E., Milanese, G., Suatoni, P., Boeri, M., et al. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.07.007 · Cited by 49
Smoking cessation strategies for patients with asthma: improving patient outcomes
Perret, J., Boneveski, B., McDonald, C., & Abramson, M. (2016) · Journal of Asthma and Allergy · doi:10.2147/jaa.s85615 · Cited by 44
E‐cigarette use in England 2014–17 as a function of socio‐economic profile
Kock, L. S., Shahab, L., West, R., & Brown, J. (2018) · Addiction · doi:10.1111/add.14446 · Cited by 43
Designer receptor technology for the treatment of epilepsy
Lieb, A., Weston, M., & Kullmann, D. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.059 · Cited by 44
Schuit, E., Panagiotou, O. A., Munafo, M. R., Bennett, D., Bergen, A. W., & David, S. P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011823.pub2 · Cited by 45
RetractedClark, A., Tate, B., Urban, B., Schroeder, R., Gennuso, S. A., Ahmadzadeh, S., McGregor, D., Girma, B., Shekoohi, S., & Kaye, A. D. (2023) · Health Psychology Research · doi:10.52965/001c.81043 · Cited by 46
Cytisine for smoking cessation: A systematic review and meta-analysis
Ofori, S., Lu, C., Olasupo, O. O., Dennis, B. B., Fairbairn, N. S., Devereaux, P. J., & Mbuagbaw, L. C. E. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110936 · Cited by 42
Windle, S. B., Dehghani, P., Roy, N., Old, W. D., Grondin, F. R., Bata, I. R., Iskander, A., Lauzon, C., Srivastava, N. K., Clarke, A., et al. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.170377 · Cited by 42
Dogar, O. F., Keding, A., Gabe, R., Marshall, A., Huque, R., Barua, D., Fatima, R., Khan, A., Zahid, R., Mansoor, S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30312-0 · Cited by 42
Schnoll, R. A., Leone, F. T., Veluz‐Wilkins, A. K., Miele, A., Hole, A. V., Jao, N. C., Wileyto, E. P., Carroll, A. J., Kalhan, R., Patel, J. D., et al. (2019) · Psycho-Oncology · doi:10.1002/pon.4978 · Cited by 42
Wang, J.-H., van Haselen, R. A., Wang, M., Yang, G., Zhang, Z., Friedrich, M., Wang, Y., Zhou, Y.-Q., Yin, M., Xiao, C.-Y., et al. (2019) · Tobacco Induced Diseases · doi:10.18332/tid/109195 · Cited by 41
Preventive care recommendations to promote health equity
Persaud, N., Sabir, A., Woods, H., Sayani, A., Agarwal, A., Chowdhury, M., de Leon-Demare, K., Ibezi, S., Jan, S. H., Katz, A., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230237 · Cited by 46
Kathuria, H., Detterbeck, F. C., Fathi, J. T., Fennig, K., Gould, M. K., Jolicoeur, D. G., Land, S. R., Massetti, G. M., Mazzone, P. J., Silvestri, G. A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201709-1858st · Cited by 40
Metadata
- Authors
- Cahill, K., Lindson-Hawley, N., Thomas, K. H., Fanshawe, T. R., & Lancaster, T.
- Affiliations
- University of Oxford (GB)
- University of Oxford; Nuffield Department of Primary Care Health Sciences; Radcliffe Observatory Quarter Woodstock Road Oxford UK OX2 6GG
- University of Bristol (GB)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-05-09
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4294253676
- Cited by
- 433
- References
- 230
- Citations by year
- 2026: 5 · 2025: 22 · 2024: 32 · 2023: 57 · 2022: 55 · 2021: 65 · 2020: 34 · 2019: 52 · 2018: 49 · 2017: 43 · 2016: 8
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Update notices
- new_version (2023-05-05)
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion, other-oa)
- Research Portal (King's College London) (submittedVersion)
- Explore Bristol Research (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (15/58/18, HTA/15/58/18, CL-2013-25-003)
- Academy of Medical Sciences (AMS-SGCL12-Thomas)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- nicotine receptor partial agonist, smoking cessation, nicotine replacement therapy, varenicline, bupropion, nicotine dependence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
